【戦略的業務提携】空間トランスクリプトマニクス・AI基盤新薬分析企業Portrai社と日本の新薬開発サポート市場進出向け戦略的業務連携へ

プレスリリース・ニュースリリース配信シェアNo.1｜PR TIMES

November 11, 2021

株式会社aixのプレスリリース（2021年11月11日 13時43分）【戦略的業務提携】空間トランスクリプトマニクス・AI基盤新薬分析企業Portrai社と日本の新薬開発サポート市場進出向け戦略的業務連携へ

Portrai to revolutionize biopsy quality through AI technology - KED Global

KED Global

October 6, 2021

Biopsy is one of the most used methods to examine a person’s illness, taking a tissue sample of a patient for analysis. Usually, the samples are thinly s

iF Design - PortraiTME

ifdesign

PortraiTME epitomizes the fusion of AI and medical research in a package designed for ultimate user engagement. The interface elegantly simplifies complex tumor micro-environment analysis, demystifying science without diluting it. The user experience is like a scalpel—precise, effective, and specialized—making intricate medical data accessible and understandable. We marry spatial transcriptomics and deep learning with a human-centered design ethos. In doing so, PortraiTME transcends being just another AI tool; it becomes an essential experience, revolutionizing diagnosis and treatment planning. Experience AI, humanized, with PortraiTME.

Hongyoon Choi | Innovators Under 35

innovatorsunder35

Our annual list of the young dreamers, tinkerers, and innovators that are creating technology’s future.

Why I chose spatial: New pathways into clinical translational research - 10x Genomics

10x Genomics

August 16, 2022

Why did Choi Hongyoon, MD, PhD, Assistant Professor at Seoul National University Hospital, choose spatial? Learn more in our blog.